CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer

Jordi Remon, Ana Collazo, Beatriz Jimenez

Résultats de recherche: Contribution à un journal › !!Comment/debate

3 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	2168-2170
Nombre de pages	3
journal	Translational Cancer Research
Volume	9
Numéro de publication	4
Les DOIs	https://doi.org/10.21037/tcr.2020.03.09
état	Publié - 1 avr. 2020
Modification externe	Oui

Accès au document

@article{792e47345c8b43be945fdcea82da2899,

title = "CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer",

author = "Jordi Remon and Ana Collazo and Beatriz Jimenez",

year = "2020",

month = apr,

day = "1",

doi = "10.21037/tcr.2020.03.09",

language = "English",

volume = "9",

pages = "2168--2170",

journal = "Translational Cancer Research",

issn = "2218-676X",

number = "4",

}

TY - JOUR

T1 - CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer

AU - Remon, Jordi

AU - Collazo, Ana

AU - Jimenez, Beatriz

PY - 2020/4/1

Y1 - 2020/4/1

UR - http://www.scopus.com/inward/record.url?scp=85085939523&partnerID=8YFLogxK

U2 - 10.21037/tcr.2020.03.09

DO - 10.21037/tcr.2020.03.09

M3 - Comment/debate

AN - SCOPUS:85085939523

SN - 2218-676X

VL - 9

SP - 2168

EP - 2170

JO - Translational Cancer Research

JF - Translational Cancer Research

IS - 4

ER -